Control Financial Statements From 2010 to 2026

Stocks . Australia . 
Stock . Control Bionics
CBL Stock   0.07  0  2.90%   
Analyzing historical trends in various income statement and balance sheet accounts from Control Bionics' financial statements helps investors evaluate the company's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Control Bionics' valuation are summarized below:
Gross Profit
4.1 M
Profit Margin
(0.99)
Market Capitalization
23.5 M
Enterprise Value Revenue
4.5947
Revenue
6.1 M
There are currently eighty-six fundamental signals for Control Bionics that can be evaluated and compared over time across rivals. All traders should validate Control Bionics' prevailing fundamentals against the performance from 2010 to 2026 and make sure the trends continue to evolve in the right direction.

Control Bionics Total Revenue

5.25 Million

Check Control Bionics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Control Bionics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.3 M, Interest Expense of 93.2 K or Selling General Administrative of 1.3 M, as well as many indicators such as . Control financial statements analysis is a perfect complement when working with Control Bionics Valuation or Volatility modules.
  
This module can also supplement various Control Bionics Technical models . Check out the analysis of Control Bionics Correlation against competitors.

Control Bionics Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets7 M7.4 M303.9 M
Slightly volatile
Short and Long Term Debt Total372.3 K391.9 K25.7 M
Slightly volatile
Total Current Liabilities2.2 M2.3 M7.6 M
Slightly volatile
Total Stockholder Equity4.7 M5 M80.6 M
Slightly volatile
Accounts Payable1.2 M1.2 M6.4 M
Slightly volatile
Cash508.5 K535.3 K109.7 M
Slightly volatile
Non Current Assets Total4.3 M4.6 M40.5 M
Slightly volatile
Cash And Short Term Investments575.1 K605.4 K110.2 M
Slightly volatile
Net Receivables1.2 M1.3 M59.7 M
Slightly volatile
Good Will89.8 M178.2 M111.7 M
Slightly volatile
Common Stock Total Equity143.2 M193.9 M148.5 M
Slightly volatile
Common Stock Shares Outstanding249.6 M237.7 M174.5 M
Pretty Stable
Liabilities And Stockholders Equity7 M7.4 M303.9 M
Slightly volatile
Non Current Liabilities Total146.1 K153.7 K27.5 M
Slightly volatile
Total Liabilities2.3 M2.5 M223.3 M
Slightly volatile
Total Current Assets2.7 M2.9 M170.3 M
Slightly volatile
Intangible Assets3.3 M3.5 M8.8 M
Pretty Stable
Common Stock43.9 M36.3 M66.6 M
Slightly volatile
Short Term Investments66.6 K70.1 K3.2 M
Slightly volatile
Net Tangible Assets5.2 M3.5 M3.4 M
Slightly volatile
Property Plant And Equipment Net602.2 K970.5 K354.2 K
Slightly volatile
Inventory447.8 K471.1 K281.8 K
Slightly volatile
Other Current Assets835 K795.2 K304.5 K
Slightly volatile
Accumulated Other Comprehensive Income430 K477.7 K591.1 K
Slightly volatile
Property Plant Equipment599 K970.5 K352.6 K
Slightly volatile
Other Liabilities19.9 K18 K15.4 K
Slightly volatile
Current Deferred Revenue188.7 K362.9 K172.9 K
Slightly volatile
Capital Lease Obligations536.9 K511.3 K163.4 K
Slightly volatile
Net Invested Capital10.1 M6.1 M15.7 M
Slightly volatile
Property Plant And Equipment Gross1.4 M2.8 M931.2 K
Slightly volatile
Capital Stock33.1 M40.4 M29.9 M
Slightly volatile
Non Current Liabilities Other800900982
Slightly volatile
Net Working Capital1.2 M1.2 M10.9 M
Slightly volatile
Short and Long Term Debt310.9 K594.7 K178.6 K
Slightly volatile

Control Bionics Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization1.3 M736.2 K3 M
Slightly volatile
Interest Expense93.2 K98.1 K3.1 M
Slightly volatile
Selling General Administrative1.3 M1.4 M10.5 M
Slightly volatile
Total Revenue5.3 M5.5 M109.1 M
Slightly volatile
Other Operating Expenses10.2 M10.8 M91.5 M
Slightly volatile
Total Operating Expenses9.1 M8.9 M14.5 M
Slightly volatile
Interest Income214.7 K204.5 K38.2 K
Slightly volatile
Selling And Marketing Expenses492.6 K475.9 K366.7 K
Slightly volatile
Research Development1.3 M1.2 M416.8 K
Slightly volatile
Cost Of Revenue2.7 M2.3 M1.9 M
Slightly volatile
Reconciled Depreciation558.3 K969.7 K375.7 K
Slightly volatile

Control Bionics Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow838.5 K882.7 K77.6 M
Slightly volatile
Depreciation1.2 M887.8 K2.4 M
Slightly volatile
Dividends Paid41.5 K43.7 K1.3 M
Pretty Stable
Capital Expenditures258.5 K272.1 K1.2 M
Slightly volatile
End Period Cash Flow508.5 K535.3 K129.7 M
Slightly volatile
Stock Based Compensation103 K142.5 K124.3 K
Slightly volatile
Issuance Of Capital Stock4.3 M4.6 M11.3 M
Slightly volatile

Control Fundamental Market Drivers

About Control Bionics Financial Statements

Control Bionics shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Control Bionics investors may analyze each financial statement separately, they are all interrelated. The changes in Control Bionics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Control Bionics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue362.9 K188.7 K
Total Revenue5.5 M5.3 M
Cost Of Revenue2.3 M2.7 M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Control Stock Analysis

When running Control Bionics' price analysis, check to measure Control Bionics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Control Bionics is operating at the current time. Most of Control Bionics' value examination focuses on studying past and present price action to predict the probability of Control Bionics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Control Bionics' price. Additionally, you may evaluate how the addition of Control Bionics to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY